1. Home
  2. IPAR vs LQDA Comparison

IPAR vs LQDA Comparison

Compare IPAR & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inter Parfums Inc.

IPAR

Inter Parfums Inc.

HOLD

Current Price

$95.96

Market Cap

2.9B

ML Signal

HOLD

LQDA

Liquidia Corporation

HOLD

Current Price

$61.18

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPAR
LQDA
Founded
1982
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
3.4B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
IPAR
LQDA
Price
$95.96
$61.18
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
11
Target Price
$116.60
$41.00
AVG Volume (30 Days)
206.1K
1.6M
Earning Date
05-05-2026
05-08-2026
Dividend Yield
3.54%
N/A
EPS Growth
2.34
51.81
EPS
1.35
0.52
Revenue
$1,317,700,000.00
$158,320,000.00
Revenue This Year
$3.86
$278.87
Revenue Next Year
$7.89
$57.13
P/E Ratio
$71.58
$119.97
Revenue Growth
21.26
1031.18
52 Week Low
$77.21
$11.85
52 Week High
$142.50
$63.46

Technical Indicators

Market Signals
Indicator
IPAR
LQDA
Relative Strength Index (RSI) 60.08 74.61
Support Level $92.30 $31.23
Resistance Level $98.64 N/A
Average True Range (ATR) 2.97 3.88
MACD 0.87 0.27
Stochastic Oscillator 89.54 91.16

Price Performance

Historical Comparison
IPAR
LQDA

About IPAR Inter Parfums Inc.

Interparfums Inc operates in the fragrance business and produces and distributes a wide array of prestige fragrance and fragrance-related products. It sells its product under the brand which includes Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Lanvin, Moncler, Montblanc, Rochas and Van Cleef & Arpels. The company operates in two operating segments namely European based operations, SA, and United States based operations. The group sells its products to department stores, perfumeries, specialty stores, and domestic and international wholesalers and distributors.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

Share on Social Networks: